药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Tetracosactide
Trimebutine
The risk or severity of hypoglycemia can be increased when Trimebutine is combined with Linagliptin.
Tetracosactide
Eperisone
The risk or severity of hypoglycemia can be increased when Eperisone is combined with Linagliptin.
Tetracosactide
Fendiline
The risk or severity of hypoglycemia can be increased when Fendiline is combined with Linagliptin.
Tetracosactide
Tranilast
The risk or severity of hypoglycemia can be increased when Tranilast is combined with Linagliptin.
Tetracosactide
Dotarizine
The risk or severity of hypoglycemia can be increased when Dotarizine is combined with Linagliptin.
Tetracosactide
Ziconotide
The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Linagliptin.
Tetracosactide
Nylidrin
The risk or severity of hypoglycemia can be increased when Nylidrin is combined with Linagliptin.
Tetracosactide
Seletracetam
The risk or severity of hypoglycemia can be increased when Seletracetam is combined with Linagliptin.
Tetracosactide
Fluspirilene
The risk or severity of hypoglycemia can be increased when Fluspirilene is combined with Linagliptin.
Tetracosactide
Flunarizine
The risk or severity of hypoglycemia can be increased when Flunarizine is combined with Linagliptin.
Tetracosactide
Cyclandelate
The risk or severity of hypoglycemia can be increased when Cyclandelate is combined with Linagliptin.
Tetracosactide
Prenylamine
The risk or severity of hypoglycemia can be increased when Prenylamine is combined with Linagliptin.
Tetracosactide
Nimesulide
The risk or severity of hypoglycemia can be increased when Nimesulide is combined with Linagliptin.
Tetracosactide
Manidipine
The risk or severity of hypoglycemia can be increased when Manidipine is combined with Linagliptin.
Tetracosactide
Xylometazoline
The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Linagliptin.
Tetracosactide
Methsuximide
The risk or severity of hypoglycemia can be increased when Methsuximide is combined with Linagliptin.
Tetracosactide
Gastric inhibitory polypeptide
The risk or severity of hypoglycemia can be increased when Linagliptin is combined with Gastric inhibitory polypeptide.
Tetracosactide
Tirzepatide
The risk or severity of hypoglycemia can be increased when Linagliptin is combined with Tirzepatide.
Tetracosactide
Englitazone
The risk or severity of hypoglycemia can be increased when Linagliptin is combined with Englitazone.
Tetracosactide
Taspoglutide
The risk or severity of hypoglycemia can be increased when Linagliptin is combined with Taspoglutide.